It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MASI’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MASI’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).
MASI (@Medical/Nursing Services) experienced а -5.99% price change this week, while SYK (@Medical/Nursing Services) price change was -0.06% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.72%. For the same industry, the average monthly price growth was +0.71%, and the average quarterly price growth was +4.00%.
MASI is expected to report earnings on Nov 11, 2025.
SYK is expected to report earnings on Oct 30, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
MASI | SYK | MASI / SYK | |
Capitalization | 7.86B | 144B | 5% |
EBITDA | -135.6M | 5.76B | -2% |
Gain YTD | -12.444 | 5.336 | -233% |
P/E Ratio | 116.80 | 50.01 | 234% |
Revenue | 2.13B | 23.8B | 9% |
Total Cash | 131M | 2.46B | 5% |
Total Debt | 682M | 16.6B | 4% |
MASI | SYK | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 15 | |
SMR RATING 1..100 | 97 | 57 | |
PRICE GROWTH RATING 1..100 | 63 | 57 | |
P/E GROWTH RATING 1..100 | 17 | 19 | |
SEASONALITY SCORE 1..100 | 75 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (76) in the Medical Specialties industry is in the same range as MASI (90). This means that SYK’s stock grew similarly to MASI’s over the last 12 months.
SYK's Profit vs Risk Rating (15) in the Medical Specialties industry is significantly better than the same rating for MASI (100). This means that SYK’s stock grew significantly faster than MASI’s over the last 12 months.
SYK's SMR Rating (57) in the Medical Specialties industry is somewhat better than the same rating for MASI (97). This means that SYK’s stock grew somewhat faster than MASI’s over the last 12 months.
SYK's Price Growth Rating (57) in the Medical Specialties industry is in the same range as MASI (63). This means that SYK’s stock grew similarly to MASI’s over the last 12 months.
MASI's P/E Growth Rating (17) in the Medical Specialties industry is in the same range as SYK (19). This means that MASI’s stock grew similarly to SYK’s over the last 12 months.
MASI | SYK | |
---|---|---|
RSI ODDS (%) | 4 days ago60% | N/A |
Stochastic ODDS (%) | 4 days ago76% | 4 days ago59% |
Momentum ODDS (%) | 4 days ago68% | 4 days ago51% |
MACD ODDS (%) | 4 days ago64% | 4 days ago49% |
TrendWeek ODDS (%) | 4 days ago70% | 4 days ago50% |
TrendMonth ODDS (%) | 4 days ago77% | 4 days ago46% |
Advances ODDS (%) | 20 days ago70% | 4 days ago56% |
Declines ODDS (%) | 12 days ago66% | 6 days ago50% |
BollingerBands ODDS (%) | 4 days ago63% | 4 days ago68% |
Aroon ODDS (%) | 4 days ago72% | 4 days ago49% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GSJY | 43.79 | 0.66 | +1.52% |
Goldman Sachs ActiveBeta® Japan Eq ETF | |||
EWN | 52.52 | 0.32 | +0.61% |
iShares MSCI Netherlands ETF | |||
FFEB | 53.53 | 0.29 | +0.54% |
FT Vest US Equity Buffer ETF Feb | |||
RZC | 25.80 | 0.11 | +0.43% |
Reinsurance Group of America | |||
HAPY | 24.21 | N/A | N/A |
Harbor Human Capital Factor Uncons ETF |
A.I.dvisor indicates that over the last year, MASI has been loosely correlated with ISRG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then ISRG could also see price increases.
Ticker / NAME | Correlation To MASI | 1D Price Change % | ||
---|---|---|---|---|
MASI | 100% | -0.12% | ||
ISRG - MASI | 48% Loosely correlated | -0.84% | ||
BSX - MASI | 48% Loosely correlated | +0.17% | ||
VCYT - MASI | 45% Loosely correlated | -1.12% | ||
SYK - MASI | 44% Loosely correlated | +0.32% | ||
MMSI - MASI | 42% Loosely correlated | -0.08% | ||
More |
A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.